DE69704093T2 - Biaryl heterocyclische Verbindungen und ihre Verwendung in der Human- oder Tiermedizin und in der Kosmetik - Google Patents

Biaryl heterocyclische Verbindungen und ihre Verwendung in der Human- oder Tiermedizin und in der Kosmetik

Info

Publication number
DE69704093T2
DE69704093T2 DE69704093T DE69704093T DE69704093T2 DE 69704093 T2 DE69704093 T2 DE 69704093T2 DE 69704093 T DE69704093 T DE 69704093T DE 69704093 T DE69704093 T DE 69704093T DE 69704093 T2 DE69704093 T2 DE 69704093T2
Authority
DE
Germany
Prior art keywords
lower alkyl
acyl
nrr
halo
heterocyclic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69704093T
Other languages
English (en)
Other versions
DE69704093D1 (de
Inventor
Philippe Diaz
Etienne Thoreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of DE69704093D1 publication Critical patent/DE69704093D1/de
Application granted granted Critical
Publication of DE69704093T2 publication Critical patent/DE69704093T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69704093T 1996-06-28 1997-06-11 Biaryl heterocyclische Verbindungen und ihre Verwendung in der Human- oder Tiermedizin und in der Kosmetik Expired - Fee Related DE69704093T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608115A FR2750426B1 (fr) 1996-06-28 1996-06-28 Nouveaux composes biaryles heterocycliques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique

Publications (2)

Publication Number Publication Date
DE69704093D1 DE69704093D1 (de) 2001-03-29
DE69704093T2 true DE69704093T2 (de) 2001-06-13

Family

ID=9493550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69704093T Expired - Fee Related DE69704093T2 (de) 1996-06-28 1997-06-11 Biaryl heterocyclische Verbindungen und ihre Verwendung in der Human- oder Tiermedizin und in der Kosmetik

Country Status (12)

Country Link
US (1) US5905088A (de)
EP (1) EP0816352B1 (de)
JP (1) JP2901577B2 (de)
AT (1) ATE199254T1 (de)
AU (1) AU701277B2 (de)
CA (1) CA2209391C (de)
DE (1) DE69704093T2 (de)
DK (1) DK0816352T3 (de)
ES (1) ES2156345T3 (de)
FR (1) FR2750426B1 (de)
GR (1) GR3035729T3 (de)
PT (1) PT816352E (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0980867B1 (de) * 1997-09-26 2007-08-08 Toray Industries, Inc. Ketonderivate und ihre medizinische verwendung
CA2330623A1 (en) * 1998-05-12 1999-11-18 Zenan Li 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
US6313309B1 (en) * 1999-04-05 2001-11-06 Ortho-Mcneil Pharmaceutical, Inc. 4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
US6998421B2 (en) 2001-06-07 2006-02-14 Biozone Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
US6495596B1 (en) 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
FR2861069B1 (fr) 2003-10-17 2005-12-09 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
WO2009012227A1 (en) 2007-07-13 2009-01-22 Board Of Regents, The University Of Texas System Hydrazone modulators of cannabinoid receptors
US9394267B2 (en) 2007-07-13 2016-07-19 The Cleveland Clinic Foundation Heterocyclic modulators of cannabinoid receptors
US9079854B2 (en) 2007-07-13 2015-07-14 The Cleveland Clinic Foundation Hydrazone modulators of cannabinoid receptors
US8440832B2 (en) 2007-07-13 2013-05-14 Board Of Regents, The University Of Texas System Heterocyclic modulators of cannabinoid receptors
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
WO2014011949A2 (en) 2012-07-13 2014-01-16 The Cleveland Clinic Foundation Neuroprotective cb2 receptor agonists
EP4037672A1 (de) 2019-10-02 2022-08-10 Institut National de la Santé et de la Recherche Médicale (INSERM) Verwendung von agonisten des retinosäurerezeptors (rar) zur umkehrung, prävention oder verzögerung der verkalkung einer aortenklappe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
FR2614618B1 (fr) * 1987-04-30 1989-07-07 Cird Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire

Also Published As

Publication number Publication date
CA2209391A1 (fr) 1997-12-28
DE69704093D1 (de) 2001-03-29
ES2156345T3 (es) 2001-06-16
EP0816352B1 (de) 2001-02-21
GR3035729T3 (en) 2001-07-31
JP2901577B2 (ja) 1999-06-07
PT816352E (pt) 2001-05-31
ATE199254T1 (de) 2001-03-15
AU2559497A (en) 1998-01-15
AU701277B2 (en) 1999-01-21
JPH1067765A (ja) 1998-03-10
FR2750426B1 (fr) 1998-08-07
DK0816352T3 (da) 2001-04-09
EP0816352A1 (de) 1998-01-07
FR2750426A1 (fr) 1998-01-02
CA2209391C (fr) 2003-05-27
US5905088A (en) 1999-05-18

Similar Documents

Publication Publication Date Title
ATE199254T1 (de) Biaryl heterocyclische verbindungen und ihre verwendung in der human- oder tiermedizin und in der kosmetik
NZ507144A (en) Benzamide derivatives useful for the treatment of diseases mediated by cytokines
NO986055L (no) Nye heterocykliske forbindelser, deres fremstilling, farmas°ytiske preparater inneholdende forbindelsene og deres anvendelse ved behandling av diabetes og beslektede sykdommer
TR200001558T2 (tr) Yeni bileşikler.
MA21502A1 (fr) 4--phenyl-(-piperazinyl)phenols et procedes pour leur preparation .
DE69103636D1 (de) Biaromatische verbindungen und ihre anwendung in menschen- und tierheilkunde und in der kosmetik.
ATE129698T1 (de) Iminoderivate, verfahren zu ihrer herstellung und ihre verwendung in der human- und tiermedizin und in der kosmetik.
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
FR2696344B1 (fr) Utilisation en teinture des fibres kératiniques de métaphénylènediamines soufrées et nouvelles métaphénylènediamines soufrées.
HUP0203431A2 (hu) Új heterociklusos vegyületek és sóik, és ezeket tartalmazó gyógyszerkészítmények, valamint felhasználásuk
ATE420634T1 (de) Zusammensetzung enthaltend ein derivat der karbaminsäure, ihre kosmetische verwendung in der kosmetik und als arzneimittel
DE69202166T2 (de) Verwendung von Tetrahydrothienopyridinderivate als Angiogenese-Inhibitoren.
ES8300745A1 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
DK227789A (da) Svovlholdige eicosanoider og deres anvendelse i laegemidler og kosmetik
ATE30725T1 (de) Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel.
DK0615971T3 (da) 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister
DE69230498D1 (de) 2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel.
DE69002340D1 (de) Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung.
DK0829470T3 (da) 2-Cyano-3,5-dihydroxy-hex-2-en-carboxylsyreamidderivater, fremgangsmåde til deres fremstilling og deres anvendelse som læge
ATE58536T1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
NO871140D0 (no) Fremgangsmaate ved fremstilling av nye 1- (3-(2-(4-morfolinyl)-etoksy)-(2-dialkylaminoetoksy)-2-tienyl)-3-fenyl-propanoner og syreaddisjonssalter derav.
IL71859A (en) 3-(1,3-dioxolan-2-yl)-pyridine derivatives,their production and their use as microbicides
ATE170848T1 (de) Oxazolidin verbindungen und ihre verwendung als arzneimittel
ES2142350T3 (es) Amidas del acido 4-oxo-acetidin-2-sulfonico y sus sales, procedimiento para su preparacion y su utilizacion.
ES2095606T3 (es) Meta-aminofenoles sustituidos en posicion 4, su procedimiento de preparacion, su empleo en la tincion de fibras queratinicas y los compuestos intermedios empleados en el procedimiento de preparacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee